Detalles de la búsqueda
1.
Cox proportional hazards deep neural network identifies peripheral blood complete remission to be at least equivalent to morphologic complete remission in predicting outcomes of patients treated with azacitidine-A prospective cohort study by the AGMT.
Am J Hematol
; 98(11): 1685-1698, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37548390
2.
Conventional versus reverse sequence of neoadjuvant epirubicin/cyclophosphamide and docetaxel: sequencing results from ABCSG-34.
Br J Cancer
; 124(11): 1795-1802, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33762716
3.
An observational, multicentre study of cabazitaxel in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel (CAPRISTANA).
BJU Int
; 123(3): 456-464, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30098093
4.
Early cerebrospinal fluid infiltration in TP53-mutated blastic plasmacytoid dendritic cell neoplasm.
Ann Hematol
; 102(2): 491-493, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36525028
5.
Aggressive NK-cell leukemia with hemophagocytosis in a Caucasian patient.
Ann Hematol
; 101(3): 721-722, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34269839
6.
Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Austrian Azacitidine Registry of the AGMT Study Group.
Int J Mol Sci
; 18(2)2017 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28212292
7.
Concomitant immune thrombocytopenia and bone marrow hemophagocytosis in a patient with SARS-CoV-2.
Clin Chem Lab Med
; 59(9): e358-e361, 2021 08 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-33721917
8.
LM02 trial Perioperative treatment with panitumumab and FOLFIRI in patients with wild-type RAS, potentially resectable colorectal cancer liver metastases-a phase II study.
Front Oncol
; 13: 1231600, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37621684
9.
Persistence of ctDNA in Patients with Breast Cancer During Neoadjuvant Treatment Is a Significant Predictor of Poor Tumor Response.
Clin Cancer Res
; 28(4): 697-707, 2022 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34862246
10.
Effect of Baseline Characteristics on Cabazitaxel Treatment Duration in Patients with Metastatic Castration-Resistant Prostate Cancer: A Post Hoc Analysis of the Compassionate Use/Expanded Access Programs and CAPRISTANA Registry.
Cancers (Basel)
; 12(4)2020 Apr 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-32316580
11.
The EndoPredict score predicts response to neoadjuvant chemotherapy and neoendocrine therapy in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer patients from the ABCSG-34 trial.
Eur J Cancer
; 134: 99-106, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32502940
12.
Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomised, neoadjuvant phase II study (ABCSG 34).
Eur J Cancer
; 132: 43-52, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32325419
13.
Safety and efficacy of neoadjuvant FOLFIRINOX treatment in a series of patients with borderline resectable pancreatic ductal adenocarcinoma.
Acta Oncol
; 52(6): 1231-3, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23445338
14.
Establishment and validation of a novel risk model for estimating time to first treatment in 120 patients with chronic myelomonocytic leukaemia.
Wien Klin Wochenschr
; 130(3-4): 115-125, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-29383443
15.
Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French-American-British and World Health Organization classifications.
J Hematol Oncol
; 9: 39, 2016 Apr 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-27084507
Resultados
1 -
15
de 15
1
Próxima >
>>